‘Pretty, and Pricey,’ Says Top Investor About Palantir Stock

Palantir Technologies reported record Q2 2025 revenue exceeding $1 billion, fueled by 93% U.S. commercial and 53% government year-over-year growth, and raised full-year guidance to $4.14-$4.15 billion, prompting a 5% after-hours share price increase. Despite these strong fundamentals and management confidence, analysts, including Jonathan Weber, caution that the stock's valuation is extremely high, trading at multiples like 100x sales, making it less attractive for new investors. This sentiment is reflected in a Wall Street consensus "Hold" rating, with an average 12-month price target indicating a nearly 30% downside.

Analysis

Palantir Technologies (PLTR) has demonstrated exceptional operational performance in its Q2 2025 earnings, surpassing the $1 billion quarterly revenue threshold for the first time and raising its full-year guidance to a range of $4.14 to $4.15 billion. This robust top-line growth is underpinned by significant momentum in both its U.S. commercial and government segments, which expanded 93% and 53% year-over-year, respectively. The market reacted positively to this fundamental strength, with the share price increasing 5% in after-hours trading, adding to a year-to-date surge of over 100%. However, this strong operational narrative is met with significant valuation concerns from market analysts. Despite stellar execution, the stock's valuation is described as "extremely high," with cautionary notes about multiples approaching 100x sales. This sentiment is broadly reflected on Wall Street, where a consensus "Hold" rating is established (7 Holds vs. 4 Buys and 3 Sells), and the average 12-month price target of $116.17 indicates a potential downside of nearly 30%, suggesting that the current share price may have fully priced in, or even surpassed, near-term growth expectations.

Key Decisions for Investors

• Given the stock's extremely high valuation and a consensus price target implying significant downside, new investors should exercise caution as the current entry point presents an unfavorable risk-reward profile.
• Existing investors who have benefited from the over 100% year-to-date gain may consider trimming their positions to realize profits, while potentially maintaining a core holding to retain exposure to the company's strong fundamental growth.
• Monitor the U.S. commercial revenue growth rate in subsequent reports, as sustained momentum in this segment is critical to justifying the stock's premium valuation and validating management's optimistic outlook.